Nasopharyngeal colonization: a target for pneumococcal vaccination (Q36689018)

15 August 2017

1 reference

title

Nasopharyngeal colonization: a target for pneumococcal vaccination (English)

1 reference

15 August 2017

2

Kari Auranen

1 reference

15 August 2017

4

Ron Dagan

1 reference

15 August 2017

3

Hanna Nohynek

1 reference

ORCID Public Data File 2021

15 August 2017

1 reference

Helena Käyhty

series ordinal

1

object named as

Helena Käyhty

1 reference

15 August 2017

Helena Mäkelä

5

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Expert Review of Vaccines

15 August 2017

published in

1 reference

15 August 2017

volume

5

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

651-667

1 reference

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Antimicrobial resistance among pediatric respiratory tract infections: clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Changing trends in antimicrobial-resistant pneumococci: it's not all bad news

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Versatility of pneumococcal surface proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Adherence molecules of pathogenic pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Differential protein expression in phenotypic variants of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

A pneumococcal pilus influences virulence and host inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Innate immunity and the pneumococcus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Antibody Responses to Nasopharyngeal Carriage ofStreptococcus pneumoniaein Adults: A Longitudinal Household Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Advances in pneumococcal vaccines: advantages for infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Vaccination against colonizing bacteria with multiple serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Pneumococcal vaccination in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Estimating the transmission parameters of pneumococcal carriage in households

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

Could a single dose of pneumococcal conjugate vaccine in children be effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.5.651

21 January 2018

Identifiers

DOI

10.1586/14760584.5.5.651

1 reference

15 August 2017

1 reference